Updated
Updated · The Washington Post · Nov 16
White House Weighs Dropping FDA Nominee Heidi Overton as 1 GOP Defection Could Sink Her
Updated
Updated · The Washington Post · Nov 16

White House Weighs Dropping FDA Nominee Heidi Overton as 1 GOP Defection Could Sink Her

1 articles · Updated · The Washington Post · Nov 16

Summary

  • Trump officials are debating whether to rescue or abandon Heidi Overton’s FDA nomination as bipartisan resistance grows ahead of a Senate health committee vote Wednesday.
  • One Republican defection could effectively kill her bid because Republicans hold just a one-seat majority on the panel, and Chair Bill Cassidy said he still has questions about her fitness.
  • Federal officials have already begun discussing alternative candidates, while GOP leaders could try to bypass the committee and force a floor vote, though that route carries procedural and political risks.
  • Overton has drawn fire from Democrats and Robert F. Kennedy Jr.’s MAHA allies over vaccines, glyphosate and flavored-vape policy, with activists launching an anti-Overton campaign targeting Murkowski, Cassidy and Collins.
  • The stakes are rising because the FDA commissioner post has been vacant since May, Trump has already withdrawn several health nominees, and Democrats are set to retake the Senate in January.

Insights

With the FDA facing a massive food safety crisis, who will step up if the current leadership nomination collapses?
Will the fierce debate over vaccine schedules and vaping policies ultimately leave America's top health agency without a permanent director?